Christian Rohlff

Chief Executive Officer & Founder Oxford BioTherapeutics

Seminars

Wednesday 5th November 2025
Presentation Sneak Peek:

Showcasing the Exciting Profiles of ADCs Targeting DLL3 & Evaluating Promising ADC Development Against Lower–Expressed Tumor Targets

  • Explaining the journey of ADC development against low-expressed tumor targets: from previously off limits to emerging advantages against modalities like TCEs
  • Diving into a case study of ADC development and profiles against DLL3
  • Exploring wider context of ADC successes and development in antigen-low populations in solid tumors 
Wednesday 5th November 2025
Presentation Sneak Peek:

Showcasing the Exciting Profiles of ADCs Targeting DLL3 & Evaluating Promising ADC Development Against Lower–Expressed Tumor Targets

  • Explaining the journey of ADC development against low-expressed tumor targets: from previously off limits to emerging advantages against modalities like TCEs
  • Diving into a case study of ADC development and profiles against DLL3
  • Exploring wider context of ADC successes and development in antigen-low populations in solid tumors 
Christian Rohlff - 16th World ADC San Diego
View all Speakers
View Event Brochure